Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B. Contract Research & Services > Clinical Trials > News
Impax introduces authorized generic of Zomig in US By PBR Staff Writer
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News Cellular enrolls 50% patients in Phase I knee osteoarthritis trial By PBR Staff Writer
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein By PBR Staff Writer
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy.
Regulatory Affairs > News
DBV, Stallergenes sign strategic research partnership targeting respiratory allergies By PBR Staff Writer
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News RuiYi, Genor sign RYI-008 development deal in China By PBR Staff Writer
RuiYi and Genor BioPharma have signed an exclusive license and collaborative development agreement for RYI-008 in China.
News Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP By PBR Staff Writer
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Contract Research & Services > Clinical Trials > News

Latest News and Insight by Sector

Production & Manufacturing

Nordion, Navidea sign contract manufacturing agreement
16 May 2013 | By PBR Staff Writer
Nordion has entered into a contract manufacturing agreement with Navidea Biopharmaceuticals for NAV5001 a diagnostic imaging agent used to detect Parkinsonian Syndromes and Dementia with Lewy Bodies.
Production & Manufacturing > Manufacturing > News
Bend Research expands manufacturing capabilities to support pharmaceutical development
15 May 2013 | By PBR Staff Writer
Bend Research has announced the expansion of its good manufacturing practice (GMP) analytical capabilities and capacity to support pharmaceutical development.
Production & Manufacturing > Manufacturing > News

Drug Research

Impax introduces authorized generic of Zomig in US
20 May 2013 | By PBR Staff Writer
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News
Almac secures BBSRC programme with UCL
17 May 2013 | By PBR Staff Writer
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Drug Research > Drug Discovery & Development > News

Inward Investment

Bayer to acquire Steigerwald Arzneimittelwerk
17 May 2013 | By PBR Staff Writer
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Inward Investment > News
Sagent Pharmaceuticals to acquire remaining stake in KSPC JV
08 May 2013 | By PBR Staff Writer
Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m.
Inward Investment > News

Packaging


Contract Research & Services

Cellular enrolls 50% patients in Phase I knee osteoarthritis trial
20 May 2013 | By PBR Staff Writer
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News
DBV, Stallergenes sign strategic research partnership targeting respiratory allergies
20 May 2013 | By PBR Staff Writer
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News

Automation

UCB, IBM collaborate on super-computer project to improve epilepsy care
17 May 2013 | By PBR Staff Writer
UCB and IBM have announced the completion of the initial phase of project designed to exploit super-computer power for better care for epilepsy patients.
Automation > IT & Software > News
PerkinElmer expands OneSource laboratory consulting services
17 May 2013 | By PBR Staff Writer
PerkinElmer has expanded its OneSource laboratory services to include strategic laboratory consulting services.
Automation > IT & Software > News

Regulatory Affairs

ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein
20 May 2013 | By PBR Staff Writer
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy.
Regulatory Affairs > News
Alethia gains US patent for cancer treatment methods
17 May 2013 | By PBR Staff Writer
Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT).
Regulatory Affairs > News

Buy the latest industry research online today!
African Pharmaceutical Directory 2013 01 February 2013 API research into pharmaceutical companies and corporations Reports Buy online from $200


Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years